O	O	0	7	Hypoxic	Hypoxic	B-NP	JJ	O	2	NMOD	O
O	O	8	17	induction	induction	I-NP	NN	O	0	ROOT	O
O	O	18	20	of	of	B-PP	IN	O	2	NMOD	O
T1	B-Protein	21	32	interleukin	interleukin	B-NP	NN	B-protein	8	NMOD	B-protein
T1	I-Protein	32	33	-	-	B-NP	HYPH	O	8	NMOD	O
T1	I-Protein	33	34	8	8	I-NP	CD	O	8	NMOD	O
O	O	35	39	gene	gene	I-NP	NN	O	8	NMOD	O
O	O	40	50	expression	expression	I-NP	NN	O	3	PMOD	O
O	O	51	53	in	in	B-PP	IN	O	2	NMOD	O
O	O	54	59	human	human	B-NP	JJ	B-cell_type	12	NMOD	B-cell_type
O	O	60	71	endothelial	endothelial	I-NP	JJ	I-cell_type	12	NMOD	I-cell_type
O	O	72	77	cells	cell	I-NP	NNS	I-cell_type	9	PMOD	I-cell_type
O	O	77	78	.	.	O	.	O	2	P	O

O	O	80	87	Because	Because	B-SBAR	IN	O	21	VMOD	O
O	O	88	97	leukocyte	leukocyte	B-NP	NN	B-cell_type	6	NMOD	B-cell_type
O	O	97	98	-	-	O	HYPH	O	6	NMOD	O
O	O	98	106	mediated	mediate	B-NP	VBN	O	6	NMOD	O
O	O	107	113	tissue	tissue	I-NP	NN	O	6	NMOD	O
O	O	114	120	damage	damage	I-NP	NN	O	7	SUB	O
O	O	121	123	is	be	B-VP	VBZ	O	1	SBAR	O
O	O	124	126	an	an	B-NP	DT	O	10	NMOD	O
O	O	127	136	important	important	I-NP	JJ	O	10	NMOD	O
O	O	137	146	component	component	I-NP	NN	O	7	PRD	O
O	O	147	149	of	of	B-PP	IN	O	10	NMOD	O
O	O	150	153	the	the	B-NP	DT	O	14	NMOD	O
O	O	154	164	pathologic	pathologic	I-NP	JJ	O	14	NMOD	O
O	O	165	172	picture	picture	I-NP	NN	O	11	PMOD	O
O	O	173	175	in	in	B-PP	IN	O	10	NMOD	O
O	O	176	184	ischemia	ischemia	B-NP	NN	O	18	NMOD	O
O	O	184	185	/	/	B-VP	SYM	O	18	NMOD	O
O	O	185	196	reperfusion	reperfusion	B-NP	NN	O	15	PMOD	O
O	O	196	197	,	,	O	,	O	21	P	O
O	O	198	200	we	we	B-NP	PRP	O	21	SUB	O
O	O	201	205	have	have	B-VP	VBP	O	0	ROOT	O
O	O	206	212	sought	seek	I-VP	VBN	O	21	VC	O
O	O	213	223	mechanisms	mechanism	B-NP	NNS	O	22	OBJ	O
O	O	224	226	by	by	B-PP	IN	O	23	NMOD	O
O	O	227	232	which	which	B-NP	WDT	O	24	PMOD	O
O	O	233	237	PMNs	PMN	B-NP	NNS	B-cell_type	27	SUB	B-cell_type
O	O	238	241	are	be	B-VP	VBP	O	24	SBAR	O
O	O	242	250	directed	direct	I-VP	VBN	O	27	VC	O
O	O	251	255	into	into	B-PP	IN	O	28	VMOD	O
O	O	256	263	hypoxic	hypoxic	B-NP	JJ	O	31	NMOD	O
O	O	264	270	tissue	tissue	I-NP	NN	O	29	PMOD	O
O	O	270	271	.	.	O	.	O	21	P	O

O	O	272	282	Incubation	Incubation	B-NP	NN	O	19	SUB	O
O	O	283	285	of	of	B-PP	IN	O	1	NMOD	O
O	O	286	291	human	human	B-NP	JJ	B-cell_type	5	NMOD	B-cell_type
O	O	292	303	endothelial	endothelial	I-NP	JJ	I-cell_type	5	NMOD	I-cell_type
O	O	304	309	cells	cell	I-NP	NNS	I-cell_type	2	PMOD	I-cell_type
O	O	310	311	(	(	O	(	O	8	DEP	O
O	O	311	314	ECs	EC	B-NP	NNS	B-cell_type	8	DEP	B-cell_type
O	O	314	315	)	)	O	)	O	5	NMOD	O
O	O	316	318	in	in	B-PP	IN	O	1	NMOD	O
O	O	319	326	hypoxia	hypoxia	B-NP	NN	O	13	NMOD	O
O	O	326	327	,	,	O	,	O	13	P	O
O	O	328	331	PO2	PO2	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	332	345	approximately	approximately	B-NP	RB	O	9	PMOD	O
O	O	346	348	14	14	I-NP	CD	O	13	AMOD	O
O	O	348	349	-	-	I-NP	HYPH	O	13	AMOD	O
O	O	349	351	18	18	I-NP	CD	O	13	AMOD	O
O	O	352	356	Torr	Torr	I-NP	NNP	O	13	NMOD	O
O	O	356	357	,	,	O	,	O	13	P	O
O	O	358	361	led	lead	B-VP	VBD	O	36	VMOD	O
O	O	362	364	to	to	B-PP	TO	O	19	VMOD	O
O	O	365	369	time	time	B-NP	NN	O	24	NMOD	O
O	O	369	370	-	-	B-NP	HYPH	O	24	NMOD	O
O	O	370	379	dependent	dependent	I-NP	JJ	O	24	NMOD	O
O	O	380	387	release	release	I-NP	NN	O	20	PMOD	O
O	O	388	390	of	of	B-PP	IN	O	24	NMOD	O
T2	B-Protein	391	393	IL	IL	B-NP	NN	B-protein	29	NMOD	B-protein
T2	I-Protein	393	394	-	-	O	HYPH	I-protein	29	NMOD	I-protein
T2	I-Protein	394	395	8	8	B-NP	CD	I-protein	29	NMOD	I-protein
O	O	396	403	antigen	antigen	I-NP	NN	I-protein	25	PMOD	I-protein
O	O	404	408	into	into	B-PP	IN	O	24	NMOD	O
O	O	409	412	the	the	B-NP	DT	O	33	NMOD	O
O	O	413	424	conditioned	condition	I-NP	VBN	O	33	NMOD	O
O	O	425	431	medium	medium	I-NP	NN	O	30	PMOD	O
O	O	431	432	;	;	O	:	O	36	P	O
O	O	433	437	this	this	B-NP	DT	O	36	SUB	O
O	O	438	441	was	be	B-VP	VBD	O	0	ROOT	O
O	O	442	453	accompanied	accompany	I-VP	VBN	O	36	VC	O
O	O	454	456	by	by	B-PP	IN	O	37	VMOD	O
O	O	457	466	increased	increase	B-NP	VBN	O	41	NMOD	O
O	O	467	478	chemotactic	chemotactic	I-NP	JJ	O	41	NMOD	O
O	O	479	487	activity	activity	I-NP	NN	O	38	PMOD	O
O	O	488	491	for	for	B-PP	IN	O	41	NMOD	O
O	O	492	496	PMNs	PMN	B-NP	NNS	B-cell_type	42	PMOD	B-cell_type
O	O	496	497	,	,	O	,	O	41	P	O
O	O	498	505	blocked	block	B-VP	VBN	O	41	NMOD	O
O	O	506	508	by	by	B-PP	IN	O	45	VMOD	O
O	O	509	517	antibody	antibody	B-NP	NN	O	46	PMOD	O
O	O	518	520	to	to	B-PP	TO	O	47	NMOD	O
T3	B-Protein	521	523	IL	IL	B-NP	NN	B-protein	50	NMOD	B-protein
T3	I-Protein	523	524	-	-	B-NP	HYPH	I-protein	48	PMOD	I-protein
T3	I-Protein	524	525	8	8	I-NP	CD	I-protein	50	NMOD	I-protein
O	O	525	526	.	.	O	.	O	36	P	O

O	O	527	537	Production	Production	B-NP	NN	O	9	SUB	O
O	O	538	540	of	of	B-PP	IN	O	1	NMOD	O
T4	B-Protein	541	543	IL	IL	B-NP	NN	B-protein	4	NMOD	B-protein
T4	I-Protein	543	544	-	-	O	HYPH	I-protein	2	PMOD	I-protein
T4	I-Protein	544	545	8	8	B-NP	CD	I-protein	4	NMOD	I-protein
O	O	546	548	by	by	B-PP	IN	O	1	NMOD	O
O	O	549	556	hypoxic	hypoxic	B-NP	JJ	O	8	NMOD	O
O	O	557	560	ECs	EC	I-NP	NNS	B-cell_type	6	PMOD	B-cell_type
O	O	561	569	occurred	occur	B-VP	VBD	O	33	VMOD	O
O	O	570	583	concomitantly	concomitantly	B-ADVP	RB	O	9	VMOD	O
O	O	584	588	with	with	B-PP	IN	O	9	VMOD	O
O	O	589	593	both	both	B-NP	DT	O	14	NMOD	O
O	O	594	603	increased	increase	I-NP	VBN	O	14	NMOD	O
O	O	604	610	levels	level	I-NP	NNS	O	11	PMOD	O
O	O	611	613	of	of	B-PP	IN	O	14	NMOD	O
T5	B-Protein	614	616	IL	IL	B-NP	NN	B-RNA	19	NMOD	B-RNA
T5	I-Protein	616	617	-	-	O	HYPH	I-RNA	19	NMOD	I-RNA
T5	I-Protein	617	618	8	8	B-NP	CD	I-RNA	19	NMOD	I-RNA
O	O	619	623	mRNA	mRNA	I-NP	NN	I-RNA	15	PMOD	I-RNA
O	O	623	624	,	,	O	,	O	14	P	O
O	O	625	630	based	base	B-PP	VBN	O	14	NMOD	O
O	O	631	633	on	on	B-PP	IN	O	21	PMOD	O
O	O	634	644	polymerase	polymerase	B-NP	NN	O	26	NMOD	O
O	O	645	650	chain	chain	I-NP	NN	O	26	NMOD	O
O	O	651	659	reaction	reaction	I-NP	NN	O	26	NMOD	O
O	O	660	668	analysis	analysis	I-NP	NN	O	22	PMOD	O
O	O	668	669	,	,	O	,	O	33	P	O
O	O	670	673	and	and	O	CC	O	33	NMOD	O
O	O	674	683	increased	increase	B-NP	VBN	O	33	NMOD	O
T6	B-Protein	684	686	IL	IL	I-NP	NN	B-protein	33	NMOD	B-protein
T6	I-Protein	686	687	-	-	O	HYPH	I-protein	33	NMOD	I-protein
T6	I-Protein	687	688	8	8	B-NP	CD	I-protein	33	NMOD	I-protein
O	O	689	702	transcription	transcription	I-NP	NN	O	0	ROOT	O
O	O	702	703	,	,	O	,	O	33	P	O
O	O	704	709	based	base	B-PP	VBN	O	33	NMOD	O
O	O	710	712	on	on	B-PP	IN	O	35	PMOD	O
O	O	713	720	nuclear	nuclear	B-NP	JJ	O	38	NMOD	O
O	O	721	724	run	run	I-NP	NN	O	36	PMOD	O
O	O	724	725	-	-	B-ADVP	HYPH	O	35	P	O
O	O	725	727	on	on	B-PP	IN	O	35	PMOD	O
O	O	728	734	assays	assay	B-NP	NNS	O	40	PMOD	O
O	O	734	735	.	.	O	.	O	33	P	O

O	O	736	744	Northern	Northern	B-NP	JJ	O	2	NMOD	O
O	O	745	753	analysis	analysis	I-NP	NN	O	9	SUB	O
O	O	754	756	of	of	B-PP	IN	O	2	NMOD	O
O	O	757	761	mRNA	mRNA	B-NP	NN	B-RNA	3	PMOD	B-RNA
O	O	762	766	from	from	B-PP	IN	O	4	NMOD	O
O	O	767	774	hypoxic	hypoxic	B-NP	JJ	O	7	NMOD	O
O	O	775	778	ECs	EC	I-NP	NNS	B-cell_type	5	PMOD	B-cell_type
O	O	779	783	also	also	B-ADVP	RB	O	9	VMOD	O
O	O	784	796	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	797	806	increased	increase	B-NP	VBN	O	11	NMOD	O
O	O	807	813	levels	level	I-NP	NNS	O	9	OBJ	O
O	O	814	816	of	of	B-PP	IN	O	11	NMOD	O
O	O	817	821	mRNA	mRNA	B-NP	NN	B-RNA	12	PMOD	B-RNA
O	O	822	825	for	for	B-PP	IN	O	13	NMOD	O
T7	B-Protein	826	836	macrophage	macrophage	B-NP	NN	B-protein	17	NMOD	B-protein
T7	I-Protein	837	848	chemotactic	chemotactic	I-NP	JJ	I-protein	17	NMOD	I-protein
T7	I-Protein	849	856	protein	protein	I-NP	NN	I-protein	19	NMOD	I-protein
T7	I-Protein	856	857	-	-	B-NP	HYPH	O	19	P	O
T7	I-Protein	857	858	1	1	I-NP	CD	O	22	NMOD	O
O	O	858	859	,	,	O	,	O	22	P	O
O	O	860	867	another	another	B-NP	DT	O	22	NMOD	O
O	O	868	874	member	member	I-NP	NN	O	14	PMOD	O
O	O	875	877	of	of	B-PP	IN	O	22	NMOD	O
O	O	878	881	the	the	B-NP	DT	O	26	NMOD	O
O	O	882	891	chemokine	chemokine	I-NP	NN	B-protein	26	NMOD	B-protein
O	O	892	903	superfamily	superfamily	I-NP	NN	I-protein	23	PMOD	I-protein
O	O	904	906	of	of	B-PP	IN	O	26	NMOD	O
O	O	907	922	proinflammatory	proinflammatory	B-NP	JJ	B-protein	29	NMOD	B-protein
O	O	923	932	cytokines	cytokine	I-NP	NNS	I-protein	27	PMOD	I-protein
O	O	932	933	.	.	O	.	O	9	P	O

T8	B-Protein	934	936	IL	IL	B-NP	NN	B-DNA	5	NMOD	B-DNA
T8	I-Protein	936	937	-	-	I-NP	HYPH	I-DNA	1	P	I-DNA
T8	I-Protein	937	938	8	8	I-NP	CD	I-DNA	5	NMOD	I-DNA
O	O	939	943	gene	gene	I-NP	NN	I-DNA	5	NMOD	I-DNA
O	O	944	953	induction	induction	I-NP	NN	O	6	SUB	O
O	O	954	957	was	be	B-VP	VBD	O	0	ROOT	O
O	O	958	968	associated	associate	I-VP	VBN	O	6	VC	O
O	O	969	973	with	with	B-PP	IN	O	7	VMOD	O
O	O	974	977	the	the	B-NP	DT	O	10	NMOD	O
O	O	978	986	presence	presence	I-NP	NN	O	8	PMOD	O
O	O	987	989	of	of	B-PP	IN	O	10	NMOD	O
O	O	990	999	increased	increase	B-NP	VBN	O	14	NMOD	O
O	O	1000	1007	binding	binding	I-NP	NN	O	14	NMOD	O
O	O	1008	1016	activity	activity	I-NP	NN	O	11	PMOD	O
O	O	1017	1019	in	in	B-PP	IN	O	10	NMOD	O
O	O	1020	1027	nuclear	nuclear	B-NP	JJ	O	17	NMOD	O
O	O	1028	1036	extracts	extract	I-NP	NNS	O	15	PMOD	O
O	O	1037	1041	from	from	B-PP	IN	O	17	NMOD	O
O	O	1042	1049	hypoxic	hypoxic	B-NP	JJ	O	20	NMOD	O
O	O	1050	1053	ECs	EC	I-NP	NNS	B-cell_type	18	PMOD	B-cell_type
O	O	1054	1057	for	for	B-PP	IN	O	17	NMOD	O
O	O	1058	1061	the	the	B-NP	DT	O	26	NMOD	O
T13,T14	B-Entity,B-Entity	1062	1064	NF	NF	I-NP	NN	B-DNA	26	NMOD	B-DNA
T13,T14	I-Entity,I-Entity	1064	1065	-	-	B-NP	HYPH	I-DNA	26	NMOD	I-DNA
T13,T14	I-Entity,I-Entity	1065	1067	kB	kB	I-NP	NN	I-DNA	26	NMOD	I-DNA
T13	I-Entity	1068	1072	site	site	I-NP	NN	I-DNA	21	PMOD	I-DNA
O	O	1072	1073	.	.	O	.	O	6	P	O

O	O	1074	1081	Studies	Study	B-NP	NNS	O	11	SUB	O
O	O	1082	1086	with	with	B-PP	IN	O	1	NMOD	O
O	O	1087	1092	human	human	B-NP	JJ	B-DNA	6	NMOD	B-DNA
O	O	1093	1102	umbilical	umbilical	I-NP	JJ	I-DNA	6	NMOD	I-DNA
O	O	1103	1107	vein	vein	I-NP	NN	I-DNA	6	NMOD	I-DNA
O	O	1108	1116	segments	segment	I-NP	NNS	I-DNA	2	PMOD	I-DNA
O	O	1117	1124	exposed	expose	B-VP	VBN	O	6	NMOD	O
O	O	1125	1127	to	to	B-PP	TO	O	7	VMOD	O
O	O	1128	1135	hypoxia	hypoxia	B-NP	NN	O	8	PMOD	O
O	O	1136	1140	also	also	B-ADVP	RB	O	11	VMOD	O
O	O	1141	1153	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	1154	1163	increased	increase	B-NP	VBN	O	13	NMOD	O
O	O	1164	1175	elaboration	elaboration	I-NP	NN	O	11	OBJ	O
O	O	1176	1178	of	of	B-PP	IN	O	13	NMOD	O
T9	B-Protein	1179	1181	IL	IL	B-NP	NN	B-protein	18	NMOD	B-protein
T9	I-Protein	1181	1182	-	-	O	HYPH	I-protein	18	NMOD	I-protein
T9	I-Protein	1182	1183	8	8	B-NP	CD	I-protein	18	NMOD	I-protein
O	O	1184	1191	antigen	antigen	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	1192	1200	compared	compare	B-PP	VBN	O	11	VMOD	O
O	O	1201	1205	with	with	B-PP	IN	O	19	PMOD	O
O	O	1206	1214	normoxic	normoxic	B-NP	JJ	O	22	NMOD	O
O	O	1215	1223	controls	control	I-NP	NNS	O	20	PMOD	O
O	O	1223	1224	.	.	O	.	O	11	P	O

O	O	1225	1227	In	In	B-PP	IN	O	16	VMOD	O
O	O	1228	1232	mice	mouse	B-NP	NNS	O	1	PMOD	O
O	O	1233	1240	exposed	expose	B-VP	VBN	O	2	NMOD	O
O	O	1241	1243	to	to	B-PP	TO	O	3	VMOD	O
O	O	1244	1251	hypoxia	hypoxia	B-NP	NN	O	4	PMOD	O
O	O	1252	1253	(	(	O	(	O	13	DEP	O
O	O	1253	1256	PO2	PO2	B-NP	NN	O	8	NMOD	O
O	O	1257	1270	approximately	approximately	B-NP	RB	O	13	DEP	O
O	O	1271	1273	30	30	I-NP	CD	O	8	AMOD	O
O	O	1273	1274	-	-	I-NP	HYPH	O	8	AMOD	O
O	O	1274	1276	40	40	I-NP	CD	O	8	AMOD	O
O	O	1277	1281	Torr	Torr	I-NP	NN	O	8	NMOD	O
O	O	1281	1282	)	)	O	)	O	5	NMOD	O
O	O	1282	1283	,	,	O	,	O	16	P	O
O	O	1284	1289	there	there	B-NP	EX	O	16	SUB	O
O	O	1290	1293	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1294	1303	increased	increase	I-VP	VBN	O	19	NMOD	O
O	O	1304	1313	pulmonary	pulmonary	B-NP	JJ	O	19	NMOD	O
O	O	1314	1325	leukostasis	leukostasis	I-NP	NN	O	16	PRD	O
O	O	1325	1326	,	,	O	,	O	16	P	O
O	O	1327	1329	as	as	B-SBAR	IN	O	16	VMOD	O
O	O	1330	1339	evidenced	evidence	B-VP	VBN	O	21	SBAR	O
O	O	1340	1342	by	by	B-PP	IN	O	22	VMOD	O
O	O	1343	1352	increased	increase	B-NP	VBN	O	26	NMOD	O
T10	B-Protein	1353	1368	myeloperoxidase	myeloperoxidase	I-NP	NN	B-protein	26	NMOD	B-protein
O	O	1369	1377	activity	activity	I-NP	NN	O	23	PMOD	O
O	O	1378	1380	in	in	B-PP	IN	O	26	NMOD	O
O	O	1381	1387	tissue	tissue	B-NP	NN	O	29	NMOD	O
O	O	1388	1399	homogenates	homogenate	I-NP	NNS	O	27	PMOD	O
O	O	1399	1400	.	.	O	.	O	16	P	O

O	O	1401	1403	In	In	B-PP	IN	O	26	VMOD	O
O	O	1404	1412	parallel	parallel	B-NP	NN	O	1	PMOD	O
O	O	1412	1413	,	,	O	,	O	26	P	O
O	O	1414	1423	increased	increase	B-NP	VBN	O	5	NMOD	O
O	O	1424	1430	levels	level	I-NP	NNS	O	26	SUB	O
O	O	1431	1433	of	of	B-PP	IN	O	5	NMOD	O
O	O	1434	1445	transcripts	transcript	B-NP	NNS	O	6	PMOD	O
O	O	1446	1449	for	for	B-PP	IN	O	7	NMOD	O
T11	B-Protein	1450	1452	IP	IP	B-NP	NN	B-protein	10	NMOD	B-protein
T11	I-Protein	1452	1453	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T11	I-Protein	1453	1455	10	10	I-NP	CD	I-protein	10	NMOD	I-protein
O	O	1455	1456	,	,	O	,	O	10	P	O
O	O	1457	1458	a	a	B-NP	DT	O	15	NMOD	O
O	O	1459	1465	murine	murine	I-NP	JJ	B-protein	15	NMOD	B-protein
O	O	1466	1475	homologue	homologue	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	1476	1478	in	in	B-PP	IN	O	15	NMOD	O
O	O	1479	1482	the	the	B-NP	DT	O	19	NMOD	O
O	O	1483	1492	chemokine	chemokine	I-NP	NN	B-protein	19	NMOD	B-protein
O	O	1493	1499	family	family	I-NP	NN	I-protein	16	PMOD	I-protein
O	O	1500	1507	related	related	B-ADJP	JJ	O	19	NMOD	O
O	O	1508	1510	to	to	B-PP	TO	O	20	AMOD	O
T12	B-Protein	1511	1513	IL	IL	B-NP	NN	B-protein	23	NMOD	B-protein
T12	I-Protein	1513	1514	-	-	B-NP	HYPH	I-protein	21	PMOD	I-protein
T12	I-Protein	1514	1515	8	8	I-NP	CD	I-protein	23	NMOD	I-protein
O	O	1515	1516	,	,	O	,	O	23	P	O
O	O	1517	1521	were	be	B-VP	VBD	O	0	ROOT	O
O	O	1522	1530	observed	observe	I-VP	VBN	O	26	VC	O
O	O	1531	1533	in	in	B-PP	IN	O	27	VMOD	O
O	O	1534	1541	hypoxic	hypoxic	B-NP	JJ	O	31	NMOD	O
O	O	1542	1546	lung	lung	I-NP	NN	O	31	NMOD	O
O	O	1547	1553	tissue	tissue	I-NP	NN	O	28	PMOD	O
O	O	1553	1554	.	.	O	.	O	26	P	O

O	O	1555	1560	Taken	Take	B-VP	VBN	O	6	VMOD	O
O	O	1561	1569	together	together	B-ADVP	RB	O	1	VMOD	O
O	O	1569	1570	,	,	O	,	O	6	P	O
O	O	1571	1576	these	these	B-NP	DT	O	5	NMOD	O
O	O	1577	1581	data	datum	I-NP	NNS	O	6	SUB	O
O	O	1582	1589	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1590	1594	that	that	B-SBAR	IN	O	6	VMOD	O
O	O	1595	1602	hypoxia	hypoxia	B-NP	NN	O	9	SUB	O
O	O	1603	1614	constitutes	constitute	B-VP	VBZ	O	7	SBAR	O
O	O	1615	1616	a	a	B-NP	DT	O	11	NMOD	O
O	O	1617	1625	stimulus	stimulus	I-NP	NN	O	9	OBJ	O
O	O	1626	1629	for	for	B-PP	IN	O	11	NMOD	O
O	O	1630	1639	leukocyte	leukocyte	B-NP	NN	O	14	NMOD	O
O	O	1640	1650	chemotaxis	chemotaxis	I-NP	NN	O	17	NMOD	O
O	O	1651	1654	and	and	O	CC	O	17	NMOD	O
O	O	1655	1661	tissue	tissue	B-NP	NN	O	17	NMOD	O
O	O	1662	1673	leukostasis	leukostasis	I-NP	NN	O	12	PMOD	O
O	O	1673	1674	.	.	O	.	O	6	P	O
